Iterum Therapeutics plc (ITRMF)
OTCMKTS
· Delayed Price · Currency is USD
0.0100
-0.0050 (-33.33%)
At close: Apr 29, 2026
Iterum Therapeutics Market Cap
Iterum Therapeutics has a market cap or net worth of $792.53 thousand as of April 29, 2026. Its market cap has decreased by -97.94% in one year.
Market Cap
792.53K
Enterprise Value
23.53M
Revenue
390.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since May 25, 2018, Iterum Therapeutics's market cap has decreased from 179.38M to 792.53K, a decrease of -99.56%. That is a compound annual growth rate of -49.52%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eastgate Biotech | 1.06M |
| Exousia Pro | 1.09M |
| International Stem Cell | 1.12M |
| Windtree Therapeutics | 1.12M |
| Evofem Biosciences | 1.15M |
| Abpro Holdings | 1.16M |
| LakeShore Biopharma | 1.24M |
| Lyra Therapeutics | 1.26M |